|
Fri, 07/11/2025 - 07:27 |
AkzoNobel marine coatings protecting worlds first sail-assisted Aframax tanker |
Akzo Nobel |
|
Fri, 07/11/2025 - 07:17 |
WuXi AppTec Issues Positive Profit Alert for the First Half of 2025 |
WuXi AppTec |
|
Wed, 07/09/2025 - 16:05 |
, have entered into a license and supply agreement for commercialization of Lupins biosimilar Certolizumab Pegol, across multiple markets globally. |
Lupin |
|
Wed, 07/09/2025 - 13:02 |
SPT Labtech and Semarion Collaborate to Advance Automated Cell-Based Assay Workflows |
SPT Labtech |
|
Wed, 07/09/2025 - 03:55 |
PBMs are Innovating to Help Patients Better Adhere to Their Medication Regimens |
PCMA net |
|
Wed, 07/09/2025 - 00:10 |
Novartis receives approval for first malaria medicine for newborn babies and young infants |
Novartis |
|
Tue, 07/08/2025 - 01:12 |
New Study Reveals Critical Misalignment Between Health Plan Utilization Management and Clinical Guidelines for Specialty Drugs |
National Pharma... |
|
Mon, 07/07/2025 - 19:24 |
WuXi AppTec Receives MSCI ESG AAA Leader Rating |
WuXi AppTec |
|
Thu, 07/03/2025 - 13:09 |
Novartis provides update on Phase III GCAptAIN study of Cosentyx in giant cell arteritis (GCA) |
Novartis |
|
Thu, 07/03/2025 - 03:22 |
eMind, Tohoku University, and Otsuka Pharmaceutical Launch Epilepsy Smart Medical Joint Research Project (Phase II) Aiming to Start and Expand Epilepsy Treatment Support System |
Otsuka |
|
Wed, 07/02/2025 - 02:07 |
Merck to Hold Second-Quarter 2025 Sales and Earnings Conference Call |
Merck |
|
Tue, 07/01/2025 - 12:37 |
Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia (certolizumab pegol) |
Advanz Pharma |
|
Mon, 06/30/2025 - 13:31 |
PCMA Statement on Todays Federal Trade Commission/Department of Justice Listening Session on Big Pharmas Anti-Competitive Behavior |
PCMA net |
|
Fri, 06/27/2025 - 18:27 |
Provectus Biopharmaceuticals Announces Publication of Moffitt Cancer Center Research on PV-10 for Head and Neck Cancer |
Provectus Bioph... |
|
Fri, 06/27/2025 - 06:51 |
WuXi AppTec Nantong Site Receives 2025 Architizer A+Award for Its Unique Blend of Technology and Humanity |
WuXi AppTec |
|
Thu, 06/26/2025 - 01:55 |
Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair (omalizumab) |
Advanz Pharma |
|
Wed, 06/25/2025 - 02:52 |
POCARI SWEAT ICE SLURRY Adopted as a New Heat Illness Prevention at Expo 2025 Osaka, Kansai, Japan, Supporting the Safe and Secure Operation of the Expo |
Otsuka |
|
Tue, 06/24/2025 - 15:41 |
10e Challenge Qualite de vie du patient : cinq projets innovants recompenses, cap vers la finale ! |
Debiopharm Group |
|
Mon, 06/23/2025 - 17:09 |
ITM and Debiopharm Announce First Patient Imaged in New Study Arm of Phase 1/2 Trial Evaluating ITM-94 as Diagnostic Agent for Clear Cell Renal Cell Carcinoma (ccRCC) |
Debiopharm Group |
|
Mon, 06/23/2025 - 12:20 |
SPT Labtech Named Illumina Qualified Methods Provider Following Successful Automation of Illumina DNA Prep on firefly Platform |
SPT Labtech |
|
Mon, 06/23/2025 - 12:20 |
European Medicines Agency Recommends Market Approval of AVT06, Alvotechs Proposed Biosimilar to Eylea (aflibercept) |
Advanz Pharma |
|
Sat, 06/21/2025 - 03:43 |
Purdue Pharma L.P. Receives Court Approval of Disclosure Statement Filed in Connection with its Plan of Reorganization |
Purdue Pharma |
|
Thu, 06/19/2025 - 04:40 |
Alnylam Announces Promotion of Pushkal Garg to Chief Research and Development Officer |
Alnylam |
|
Wed, 06/18/2025 - 06:55 |
WuXi AppTec Earns SBTi Validation for Near-Term Emissions Reduction Targets |
WuXi AppTec |
|
Tue, 06/17/2025 - 09:03 |
Kamada Confirms Continuous Global Business Operations and Products Availability Despite Recent Events in the Middle East |
Kamada |
